We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.9B
1-Year Est. Return 39.77%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+39.77%
3 Year Est. Return
+108.07%
5 Year Est. Return
+139.85%
10 Year Est. Return
+551.6%
AUM
$452M
AUM Growth
-$4.06M
Cap. Flow
-$1.04M
Cap. Flow %
-0.23%
Top 10 Hldgs %
21.76%
Holding
443
New
25
Increased
18
Reduced
19
Closed
20

Top Buys

Rank Stock Value
1
FLS icon
Flowserve
FLS
+$1.05M
2
AAL icon
American Airlines Group
AAL
+$943K
3
APTV icon
Aptiv
APTV
+$438K
4
BKR icon
Baker Hughes
BKR
+$433K
5
KHC icon
Kraft Heinz
KHC
+$425K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$701K
2
SPG icon
Simon Property Group
SPG
+$668K
3
CMCSA icon
Comcast
CMCSA
+$643K
4
NKTR icon
Nektar Therapeutics
NKTR
+$606K
5
PEP icon
PepsiCo
PEP
+$507K

Sector Composition

Rank Sector Weight
1 Technology 19.36%
2 Financials 17.3%
3 Healthcare 15.08%
4 Communication Services 10.39%
5 Consumer Discretionary 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
B
376
DELISTED
Barnes Group Inc.
B
$221K 0.05%
3,690
– –
CBU icon
377
Community Bank
CBU
$3.47B
$219K 0.05%
+4,080
New +$222K
JJSF icon
378
J&J Snack Foods
JJSF
$1.55B
$218K 0.05%
1,600
– –
KWR icon
379
Quaker Houghton
KWR
$2.98B
$216K 0.05%
1,460
– –
MED icon
380
Medifast
MED
$144M
$216K 0.05%
+2,310
New +$173K
INGN icon
381
Inogen
INGN
$177M
$215K 0.05%
1,750
– –
AIT icon
382
Applied Industrial Technologies
AIT
$13.2B
$213K 0.05%
+2,920
New +$209K
BPFH
383
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$213K 0.05%
14,160
– –
NEOG icon
384
Neogen
NEOG
$2.53B
$211K 0.05%
+6,306
New +$190K
LGND icon
385
Ligand Pharmaceuticals
LGND
$6.02B
$210K 0.05%
+2,036
New +$201K
EBS icon
386
Emergent Biosolutions
EBS
$391M
$208K 0.05%
+3,960
New +$197K
WWW icon
387
Wolverine World Wide
WWW
$1.62B
$208K 0.05%
7,210
– –
BLD
388
DELISTED
TopBuild
BLD
$207K 0.05%
2,710
– –
AKAM icon
389
Akamai
AKAM
$17.8B
$206K 0.05%
2,899
-2,170
-43% -$148K
FFIN icon
390
First Financial Bankshares
FFIN
$5.05B
$204K 0.05%
+8,820
New +$207K
BRKL
391
DELISTED
Brookline Bancorp
BRKL
$203K 0.04%
+12,520
New +$205K
DAR icon
392
Darling Ingredients
DAR
$9.25B
$203K 0.04%
11,730
– –
SFLY
393
DELISTED
Shutterfly, Inc.
SFLY
$203K 0.04%
+2,500
New +$174K
PRLB icon
394
Protolabs
PRLB
$2.12B
$202K 0.04%
+1,720
New +$194K
DOC icon
395
Healthpeak Properties
DOC
$15B
$201K 0.04%
8,647
– –
FWRD icon
396
Forward Air
FWRD
$475M
$201K 0.04%
3,800
– –
SEM
397
DELISTED
Select Medical
SEM
$201K 0.04%
21,660
– –
LXP icon
398
LXP Industrial Trust
LXP
$3.58B
$154K 0.03%
3,902
– –
VIAV icon
399
Viavi Solutions
VIAV
$9.81B
$152K 0.03%
15,670
– –
CCRN
400
DELISTED
Cross Country Healthcare
CCRN
$148K 0.03%
+13,360
New +$167K
14 15
16
17 18

Similar funds

DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Everence Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Everence Capital Management held 443 positions worth $452M, down 0.89% from $456M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Everence Capital Management's Q1 2018 filing shows 25 new, 18 increased, 19 reduced and 20 closed positions. Its largest new stake was Flowserve: 24,000 shares worth $1.04M. The largest sale was Apple, an estimated $701K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Everence Capital Management's largest Q1 2018 buy was Flowserve: 24,000 shares worth $1.04M.
  • Everence Capital Management added most to Baker Hughes in Q1 2018, an estimated $433K increase.
  • Everence Capital Management's biggest Q1 2018 reduction was Apple, cutting an estimated $701K.
  • Everence Capital Management fully exited Nektar Therapeutics in Q1 2018, selling an estimated $606K.
  • Everence Capital Management's ten largest holdings make up 22% of its $452M portfolio in Q1 2018.
  • Everence Capital Management opened 25 new positions and closed 20 in Q1 2018.
  • Everence Capital Management's portfolio value fell 0.89% quarter-over-quarter to $452M.

Based on Everence Capital Management's 13F filing for Q1 2018, filed 30 Apr 2018.